DRUG: Bright Minds Biosciences Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | 13G amendment | Cormorant Asset Management, LP | 9.17% | SEC | |
| 2026-08-12 | Fell below 5% | Adage Capital Management, L.P. | 3.41% | SEC |
Institutional ownership (Q2 2026)
99 institutions reported holding $653.35M of Bright Minds Biosciences Inc. on Form 13F (94 the quarter before). 18 opened a new position and 12 sold out. Shares held by institutions: +1%.
| Largest holders | Shares | Value |
|---|---|---|
| Jupiter Topco LLC | 1,349,107 | $94.82M |
| Cormorant Asset Management, LP | 900,000 | $63.18M |
| BlackRock, Inc. | 686,184 | $48.17M |
| Vivo Capital, LLC | 557,172 | $39.11M |
| Vestal Point Capital, LP | 545,000 | $38.26M |
| BRAIDWELL LP | 483,822 | $33.96M |
| Driehaus Capital Management LLC | 433,377 | $30.42M |
| Balyasny Asset Management L.P. | 345,053 | $24.22M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 335,000 | $23.52M |
| Point72 Asset Management, L.P. | 327,416 | $22.98M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.